Role of gp130‐mediated signalling pathways in the heart and its impact on potential therapeutic aspects

[1]  G. Mayer,et al.  Oncostatin M-induced effects on EMT in human proximal tubular cells: differential role of ERK signaling. , 2007, American journal of physiology. Renal physiology.

[2]  R. Kishore,et al.  STAT3-Dependent Mouse Embryonic Stem Cell Differentiation Into Cardiomyocytes: Analysis of Molecular Signaling and Therapeutic Efficacy of Cardiomyocyte Precommitted mES Transplantation in a Mouse Model of Myocardial Infarction , 2007, Circulation research.

[3]  G. Booz,et al.  Evidence that IL‐6‐type cytokine signaling in cardiomyocytes is inhibited by oxidative stress: Parthenolide targets JAK1 activation by generating ROS , 2007, Journal of cellular physiology.

[4]  M. Fortuño,et al.  Loss of myocardial LIF receptor in experimental heart failure reduces cardiotrophin-1 cytoprotection. A role for neurohumoral agonists? , 2007, Cardiovascular research.

[5]  C. Fielding,et al.  Classic interleukin-6 receptor signaling and interleukin-6 trans-signaling differentially control angiotensin II-dependent hypertension, cardiac signal transducer and activator of transcription-3 activation, and vascular hypertrophy in vivo. , 2007, The American journal of pathology.

[6]  G. Maurer,et al.  Vascular Endothelial Growth Factor Is Induced by the Inflammatory Cytokines Interleukin-6 and Oncostatin M in Human Adipose Tissue In Vitro and in Murine Adipose Tissue In Vivo , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[7]  G. Hasenfuss,et al.  Generation of Functional Cardiomyocytes From Adult Mouse Spermatogonial Stem Cells , 2007, Circulation research.

[8]  G. Stark,et al.  Unphosphorylated STAT3 accumulates in response to IL-6 and activates transcription by binding to NFkappaB. , 2007, Genes & development.

[9]  W. Gerald,et al.  Stat3 is tyrosine-phosphorylated through the interleukin-6/glycoprotein 130/Janus kinase pathway in breast cancer , 2007, Breast Cancer Research.

[10]  S. Brand,et al.  SOCS1 silencing enhances antitumor activity of type I IFNs by regulating apoptosis in neuroendocrine tumor cells. , 2007, Cancer research.

[11]  I. Kawase,et al.  Identification of cardiac myocytes as the target of interleukin 11, a cardioprotective cytokine. , 2007, Cytokine.

[12]  G. Lesinski,et al.  IFN-α-Induced Signal Transduction, Gene Expression, and Antitumor Activity of Immune Effector Cells Are Negatively Regulated by Suppressor of Cytokine Signaling Proteins1 , 2007, The Journal of Immunology.

[13]  K. Lillemoe,et al.  Deficiency of TNFR1 protects myocardium through SOCS3 and IL-6 but not p38 MAPK or IL-1beta. , 2007, American journal of physiology. Heart and circulatory physiology.

[14]  M. Kubo,et al.  Overexpression of Suppressor of Cytokine Signaling-3 in T Cells Exacerbates Acetaminophen-Induced Hepatotoxicity1 , 2007, The Journal of Immunology.

[15]  I. Chaudry,et al.  Anti-rat soluble IL-6 receptor antibody down-regulates cardiac IL-6 and improves cardiac function following trauma-hemorrhage. , 2007, Journal of molecular and cellular cardiology.

[16]  D. Santini,et al.  p66Shc/Notch‐3 Interplay Controls Self‐Renewal and Hypoxia Survival in Human Stem/Progenitor Cells of the Mammary Gland Expanded In Vitro as Mammospheres , 2007, Stem cells.

[17]  K. Sliwa,et al.  A Cathepsin D-Cleaved 16 kDa Form of Prolactin Mediates Postpartum Cardiomyopathy , 2007, Cell.

[18]  W. Alexander,et al.  Opposing roles of gp130‐mediated STAT‐3 and ERK‐1/2 signaling in liver progenitor cell migration and proliferation , 2007, Hepatology.

[19]  D. Hilfiker-Kleiner,et al.  Survival pathways in hypertrophy and heart failure: The gp130-STAT3 axis , 2007, Basic Research in Cardiology.

[20]  A. Yoshimura,et al.  Innate Defense Mechanism Against Virus Infection Within the Cardiac Myocyte Requiring gp130-STAT3 Signaling , 2006, Circulation.

[21]  M. Fortuño,et al.  Differential hypertrophic effects of cardiotrophin-1 on adult cardiomyocytes from normotensive and spontaneously hypertensive rats. , 2006, Journal of molecular and cellular cardiology.

[22]  B. Pedersen,et al.  The role of IL-6 in mediating the anti-inflammatory effects of exercise. , 2006, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[23]  G. Inghirami,et al.  β4 Integrin Amplifies ErbB2 Signaling to Promote Mammary Tumorigenesis , 2006, Cell.

[24]  U. Klingmüller,et al.  Forced dimerization of gp130 leads to constitutive STAT3 activation, cytokine-independent growth, and blockade of differentiation of embryonic stem cells. , 2006, Molecular biology of the cell.

[25]  Seiya Kato,et al.  IFNγ-dependent, spontaneous development of colorectal carcinomas in SOCS1-deficient mice , 2006, The Journal of experimental medicine.

[26]  J. Zweier,et al.  Transcriptome analysis of the ischemia-reperfused remodeling myocardium: temporal changes in inflammation and extracellular matrix. , 2006, Physiological genomics.

[27]  E. Benveniste,et al.  IFN‐β‐induced SOCS‐1 negatively regulates CD40 gene expression in macrophages and microglia , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[28]  Stefan Wagner,et al.  Pluripotency of spermatogonial stem cells from adult mouse testis , 2006, Nature.

[29]  I. Chaudry,et al.  Mechanism of IL-6-mediated cardiac dysfunction following trauma-hemorrhage. , 2006, Journal of molecular and cellular cardiology.

[30]  K. Nakao,et al.  SOCS1/JAB likely mediates the protective effect of cardiotrophin-1 against lipopolysaccharide-induced left ventricular dysfunction in vivo. , 2005, Circulation journal : official journal of the Japanese Circulation Society.

[31]  J. Stephens,et al.  Cross-talk among gp130 Cytokines in Adipocytes* , 2005, Journal of Biological Chemistry.

[32]  S. Ogawa,et al.  Interleukin-6/soluble interleukin-6 receptor complex reduces infarct size via inhibiting myocardial apoptosis , 2005, Laboratory Investigation.

[33]  E. Stefani,et al.  Molecular and Functional Signature of Heart Hypertrophy During Pregnancy , 2005, Circulation research.

[34]  A. Roberts,et al.  The threshold of gp130-dependent STAT3 signaling is critical for normal regulation of hematopoiesis. , 2005, Blood.

[35]  I. Dixon,et al.  Emerging evidence for the role of cardiotrophin-1 in cardiac repair in the infarcted heart. , 2005, Cardiovascular research.

[36]  J. Grandis,et al.  In vivo antitumor efficacy of STAT3 blockade using a transcription factor decoy approach: implications for cancer therapy , 2005, Oncogene.

[37]  D. Levy,et al.  Novel roles of unphosphorylated STAT3 in oncogenesis and transcriptional regulation. , 2005, Cancer research.

[38]  K. Nakao,et al.  Hypertrophic responses to cardiotrophin-1 are not mediated by STAT3, but via a MEK5-ERK5 pathway in cultured cardiomyocytes. , 2005, Journal of molecular and cellular cardiology.

[39]  S. Ogawa,et al.  Involvement of gp130-mediated signaling in pressure overload-induced activation of the JAK/STAT pathway in rodent heart , 2005, Heart and Vessels.

[40]  G. Christensen,et al.  Leukemia inhibitory factor reduces contractile function and induces alterations in energy metabolism in isolated cardiomyocytes. , 2004, Journal of molecular and cellular cardiology.

[41]  M. Berry,et al.  Targeted overexpression of leukemia inhibitory factor to preserve myocardium in a rat model of postinfarction heart failure. , 2004, The Journal of thoracic and cardiovascular surgery.

[42]  J. Turkson,et al.  STAT proteins as novel targets for cancer drug discovery , 2004, Expert opinion on therapeutic targets.

[43]  P. Heinrich,et al.  Inhibition of gp130 Signaling in Breast Cancer Blocks Constitutive Activation of Stat3 and Inhibits in Vivo Malignancy , 2004, Cancer Research.

[44]  M. Trikha,et al.  CNTO 328, a monoclonal antibody to IL‐6, inhibits human tumor‐induced cachexia in nude mice , 2004, International journal of cancer.

[45]  N. Nakatsuji,et al.  STAT3 Is Dispensable for Maintenance of Self‐Renewal in Nonhuman Primate Embryonic Stem Cells , 2004, Stem cells.

[46]  Holm Zaehres,et al.  LIF/STAT3 Signaling Fails to Maintain Self‐Renewal of Human Embryonic Stem Cells , 2004, Stem cells.

[47]  Hui Zhang,et al.  Different contributions of STAT3, ERK1/2, and PI3-K signaling to cardiomyocyte hypertrophy by cardiotrophin-1. , 2004, Acta pharmacologica Sinica.

[48]  Y. Fujio,et al.  Circulating interleukin-6 family cytokines and their receptors in patients with congestive heart failure , 2004, Heart and Vessels.

[49]  Michael D. Schneider,et al.  Signal Transducer and Activator of Transcription 3 Is Required for Myocardial Capillary Growth, Control of Interstitial Matrix Deposition, and Heart Protection From Ischemic Injury , 2004, Circulation research.

[50]  Y. Takeishi,et al.  Activation of distinct signal transduction pathways in hypertrophied hearts by pressure and volume overload , 2004, Basic Research in Cardiology.

[51]  Ana D. Lopez,et al.  Maintenance of Pluripotency in Human Embryonic Stem Cells Is STAT3 Independent , 2004, Stem cells.

[52]  R. Rossen,et al.  Inflammation and Ischemia: Macrophages Activated by Fibronectin Fragments Enhance the Survival of Injured Cardiac Myocytes , 2004, Experimental biology and medicine.

[53]  J. Johnston.  Are SOCS suppressors, regulators, and degraders? , 2004, Journal of leukocyte biology.

[54]  E. Olson.  A decade of discoveries in cardiac biology , 2004, Nature Medicine.

[55]  Y. Mándi,et al.  Comparative study of the roles of cytokines and apoptosis in dilated and hypertrophic cardiomyopathies. , 2004, European cytokine network.

[56]  G. Christensen,et al.  Leukaemia inhibitory factor alters expression of genes involved in rat cardiomyocyte energy metabolism. , 2004, Acta physiologica Scandinavica.

[57]  B. Jenkins,et al.  Acquiring signalling specificity from the cytokine receptor gp130. , 2004, Trends in genetics : TIG.

[58]  R. Mason,et al.  Oncostatin M, a cytokine released by activated mononuclear cells, induces epithelial cell-myofibroblast transdifferentiation via Jak/Stat pathway activation. , 2004, Journal of the American Society of Nephrology : JASN.

[59]  G. Lip,et al.  Prognostic value of interleukin‐6, plasma viscosity, fibrinogen, von Willebrand factor, tissue factor and vascular endothelial growth factor levels in congestive heart failure , 2003, European journal of clinical investigation.

[60]  S. S. Zhang,et al.  Cardiomyocyte-restricted knockout of STAT3 results in higher sensitivity to inflammation, cardiac fibrosis, and heart failure with advanced age , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[61]  M. Puato,et al.  C-reactive protein and interleukin-6 in vascular disease: culprits or passive bystanders? , 2003, Journal of hypertension.

[62]  R. Montesano,et al.  Loss of active MEK1-ERK1/2 restores epithelial phenotype and morphogenesis in transdifferentiated MDCK cells. , 2003, American journal of physiology. Cell physiology.

[63]  G. Maurer,et al.  Glycoprotein 130 ligand oncostatin-M induces expression of vascular endothelial growth factor in human adult cardiac myocytes. , 2003, Cardiovascular research.

[64]  P. Heinrich,et al.  Principles of interleukin (IL)-6-type cytokine signalling and its regulation. , 2003, The Biochemical journal.

[65]  I. Komuro,et al.  Leukemia Inhibitory Factor Enhances Survival of Cardiomyocytes and Induces Regeneration of Myocardium After Myocardial Infarction , 2003, Circulation.

[66]  T. Hirano,et al.  Activation of gp130 Transduces Hypertrophic Signal Through Interaction of Scaffolding/Docking Protein Gab1 With Tyrosine Phosphatase SHP2 in Cardiomyocytes , 2003, Circulation research.

[67]  C. Rücker-Martin,et al.  Human cardiomyocyte hypertrophy induced in vitro by gp130 stimulation. , 2003, Cardiovascular research.

[68]  S. Akira,et al.  IL-6 induces an anti-inflammatory response in the absence of SOCS3 in macrophages , 2003, Nature Immunology.

[69]  K. Igarashi,et al.  Requirement of gp130 signaling for the AGM hematopoiesis. , 2003, Experimental hematology.

[70]  J. Grandis,et al.  Targeted inhibition of Stat3 with a decoy oligonucleotide abrogates head and neck cancer cell growth , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[71]  A. Lichtenberg,et al.  Alterations in Janus Kinase (JAK)-Signal Transducers and Activators of Transcription (STAT) Signaling in Patients With End-Stage Dilated Cardiomyopathy , 2003, Circulation.

[72]  N. El-Sherif,et al.  The functional role of the JAK-STAT pathway in post-infarction remodeling. , 2003, Cardiovascular research.

[73]  P. Heinrich,et al.  Signal transducer and activator of transcription STAT3 plays a major role in gp130-mediated acute phase protein gene activation. , 2003, Acta biochimica Polonica.

[74]  K. Yamauchi-Takihara.  Gp130-mediated pathway and left ventricular remodeling. , 2002, Journal of cardiac failure.

[75]  F. Gao,et al.  Regulation of cardiac fibroblast cellular function by leukemia inhibitory factor. , 2002, Journal of molecular and cellular cardiology.

[76]  H. Masutani,et al.  Overexpression of Thioredoxin-1 in Transgenic Mice Attenuates Adriamycin-Induced Cardiotoxicity , 2002, Circulation.

[77]  Austin G Smith,et al.  Signalling, cell cycle and pluripotency in embryonic stem cells. , 2002, Trends in cell biology.

[78]  I. Kawase,et al.  Cardiac-specific Activation of Signal Transducer and Activator of Transcription 3 Promotes Vascular Formation in the Heart* , 2002, The Journal of Biological Chemistry.

[79]  J. Burnett,et al.  Cardiotrophin-1 Stimulation of Cardiac Fibroblast Growth: Roles for Glycoprotein 130/Leukemia Inhibitory Factor Receptor and the Endothelin Type A Receptor , 2002, Circulation research.

[80]  J. Ross,et al.  Suppressor of cytokine signaling-3 is a biomechanical stress-inducible gene that suppresses gp130-mediated cardiac myocyte hypertrophy and survival pathways. , 2001, The Journal of clinical investigation.

[81]  J. Pepper,et al.  Quantitative Myocardial Cytokine Expression and Activation of the Apoptotic Pathway in Patients Who Require Left Ventricular Assist Devices , 2001, Circulation.

[82]  B. McManus,et al.  Overexpression of interleukin-6 aggravates viral myocarditis: impaired increase in tumor necrosis factor-alpha. , 2001, Journal of molecular and cellular cardiology.

[83]  Y. Fujio,et al.  Activation of Signal Transducer and Activator of Transcription 3 Protects Cardiomyocytes from Hypoxia/Reoxygenation-Induced Oxidative Stress Through the Upregulation of Manganese Superoxide Dismutase , 2001, Circulation.

[84]  Y. Hiroi,et al.  gp130 Plays a Critical Role in Pressure Overload-induced Cardiac Hypertrophy* , 2001, The Journal of Biological Chemistry.

[85]  G. Christensen,et al.  Myocardial gene expression of leukaemia inhibitory factor, interleukin‐6 and glycoprotein 130 in end‐stage human heart failure , 2001, European journal of clinical investigation.

[86]  D. Mann,et al.  Functional Significance of Hemodynamic Overload–Induced Expression of Leukemia-Inhibitory Factor in the Adult Mammalian Heart , 2001, Circulation.

[87]  Y. Fujio,et al.  Glycoprotein 130 Regulates Cardiac Myocyte Survival in Doxorubicin-Induced Apoptosis Through Phosphatidylinositol 3-Kinase/Akt Phosphorylation and Bcl-xL/Caspase-3 Interaction , 2001, Circulation.

[88]  J. Jansson,et al.  Normal pharmacologically-induced, but decreased regenerative liver growth in interleukin-6-deficient (IL-6(-/-)) mice. , 2000, Journal of hepatology.

[89]  M. Kinoshita,et al.  High levels of plasma brain natriuretic peptide and interleukin-6 after optimized treatment for heart failure are independent risk factors for morbidity and mortality in patients with congestive heart failure. , 2000, Journal of the American College of Cardiology.

[90]  T. Kishimoto,et al.  gp130-Dependent signalling pathway is not enhanced in gp130 transgenic heart after LIF stimulation. , 2000, Cytokine.

[91]  T. Kishimoto,et al.  A novel role for STAT3 in cardiac remodeling. , 2000, Trends in cardiovascular medicine.

[92]  S. Ogawa,et al.  Significance of ERK cascade compared with JAK/STAT and PI3-K pathway in gp130-mediated cardiac hypertrophy. , 2000, American journal of physiology. Heart and circulatory physiology.

[93]  T. Kishimoto,et al.  Activation of JAK/STAT pathway transduces cytoprotective signal in rat acute myocardial infarction. , 2000, Cardiovascular research.

[94]  D. Metcalf,et al.  The development of fatal myocarditis and polymyositis in mice heterozygous for IFN-gamma and lacking the SOCS-1 gene. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[95]  T. Luedde,et al.  Interleukin 6 and liver regeneration , 2000, Gut.

[96]  Y. Shiki,et al.  Oncostatin M is produced during pregnancy by decidual cells and stimulates the release of HCG. , 2000, Molecular human reproduction.

[97]  G. Sanz,et al.  Prognostic value of serum cytokines in patients with congestive heart failure. , 2000, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[98]  Y. Fujio,et al.  Signal Transducer and Activator of Transcription 3 Is Required for Glycoprotein 130-mediated Induction of Vascular Endothelial Growth Factor in Cardiac Myocytes* , 2000, The Journal of Biological Chemistry.

[99]  M. Okabe,et al.  Signal transducer and activator of transcription 3 in the heart transduces not only a hypertrophic signal but a protective signal against doxorubicin-induced cardiomyopathy. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[100]  M. Katsuki,et al.  STAT3 activation is sufficient to maintain an undifferentiated state of mouse embryonic stem cells , 1999, The EMBO journal.

[101]  J. Ross,et al.  Loss of a gp130 Cardiac Muscle Cell Survival Pathway Is a Critical Event in the Onset of Heart Failure during Biomechanical Stress , 1999, Cell.

[102]  V. Praloran,et al.  The presence in human serum of a circulating soluble leukemia inhibitory factor receptor (sgp190) and its evolution during pregnancy. , 1999, European cytokine network.

[103]  J. Nichols,et al.  Paracrine induction of stem cell renewal by LIF-deficient cells: a new ES cell regulatory pathway. , 1998, Developmental biology.

[104]  G. Sanz,et al.  Serum interleukin-6 in congestive heart failure secondary to idiopathic dilated cardiomyopathy. , 1998, The American journal of cardiology.

[105]  P. Heinrich,et al.  Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway. , 1998, The Biochemical journal.

[106]  Y. Fujio,et al.  Activation of gp130 transduces hypertrophic signals via STAT3 in cardiac myocytes. , 1998, Circulation.

[107]  Y. Fujio,et al.  Activation of Phosphatidylinositol 3-Kinase through Glycoprotein 130 Induces Protein Kinase B and p70 S6 Kinase Phosphorylation in Cardiac Myocytes* , 1998, The Journal of Biological Chemistry.

[108]  D. Fukai,et al.  Interleukin-6 spillover in the peripheral circulation increases with the severity of heart failure, and the high plasma level of interleukin-6 is an important prognostic predictor in patients with congestive heart failure. , 1998, Journal of the American College of Cardiology.

[109]  T. Hirano,et al.  Signaling mechanisms through gp130: a model of the cytokine system. , 1997, Cytokine & growth factor reviews.

[110]  S. Ogawa,et al.  Leukemia inhibitory factor, a potent cardiac hypertrophic cytokine, activates the JAK/STAT pathway in rat cardiomyocytes. , 1997, Circulation research.

[111]  K. Chien,et al.  Cardiotrophin-1 and the role of gp130-dependent signaling pathways in cardiac growth and development , 1997, Journal of Molecular Medicine.

[112]  Y. Fujio,et al.  Activation of JAK-STAT and MAP kinases by leukemia inhibitory factor through gp130 in cardiac myocytes. , 1996, Circulation.

[113]  J. Heath,et al.  Cardiotrophin-1 Activates a Distinct Form of Cardiac Muscle Cell Hypertrophy , 1996, The Journal of Biological Chemistry.

[114]  K. Chien,et al.  Cardiotrophin-1 displays early expression in the murine heart tube and promotes cardiac myocyte survival. , 1996, Development.

[115]  K. Shiota,et al.  Targeted disruption of gp130, a common signal transducer for the interleukin 6 family of cytokines, leads to myocardial and hematological disorders. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[116]  M. Sakata,et al.  Soluble interleukin-6 (IL-6) receptor in the sera of pregnant women forms a complex with IL-6 and augments human chorionic gonadotropin production by normal human trophoblasts through binding to the IL-6 signal transducer. , 1995, The Journal of clinical endocrinology and metabolism.

[117]  T. Kishimoto,et al.  Continuous activation of gp130, a signal-transducing receptor component for interleukin 6-related cytokines, causes myocardial hypertrophy in mice. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[118]  A. Ogata,et al.  Hypoxic stress induces cardiac myocyte-derived interleukin-6. , 1995, Circulation.